The skinache syndrome.
Chronic pain of unknown aetiology, and characterized by cutaneous trigger points, has been coined the skinache syndrome. The treatment of the skinache syndrome was evaluated in 94 patients by two independent methods 2 years after treatment. After one subcutaneous injection of lidocaine 68% of the patients were cured. The pain recurred in 27 patients having suffered for an average of 2 years. Surgical removal of the cutaneous trigger points cured 77% of the latter patients. The odds ratio of success of surgical treatment versus all other treatments combined was 101.3. The skinache syndrome requires a precise clinical investigation. Even when the origin of the pain in tendons, muscle and adipose tissue is excluded, the skinache syndrome remains a common, debilitating disorder. In contrast to fibromyalgia, the skinache syndrome has a simple and effective cure.
Bassøe
C F
CF
Promed Institute, Bergen, Norway.
D000368:Aged; D000779:Anesthetics, Local / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D059408:Pain Management; D012871:Skin Diseases / Q000628:therapy*; D013577:Syndrome
D000779:Anesthetics, Local; D008012:Lidocaine